Cancer Diagnostics, Inc. (CDI) manufactures, develops and supplies products for the worldwide anatomical pathology market. (Surgical Pathology, Histology, Cytology, & Immunohistochemistry). Founded in 1998, CDI developed the first commercially available 7-dye color kit for marking and identifying cancer margins and today has grown into one of the industry's largest providers to anatomical pathology serving over 3,500 customers throughout the world.